General anesthesia with neuromuscular blockade
Conditions
Interventions
None listed
Sponsors
Hamamatsu University School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients undergoing general anesthesia Aged 75 years or older Obtained informed consent
Exclusion criteria
Exclusion criteria: Patients taking cholinesterase inhibitors other than donepezil History of allergy to general anesthetic agents Severe obesity or cachexia Presence of a pacemaker or implantable cardioverter-defibrillator (ICD) Presence of prosthetic devices in the upper limbs Inappropriate indication for the use of neuromuscular blocking agents Inappropriate for intravenous anesthetic induction Presence of organ dysfunction Emergency surgery Deemed ineligible by the investigators
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time from Rocuronium Administration to Onset of Complete Neuromuscular Blockade Time Required for Recovery from Neuromuscular Blockade | — |
Secondary
| Measure | Time frame |
|---|---|
| The association between differences in patient populations and variations in general anesthesia management, including the types and dosages of anesthetic agents, concomitant medications, and vital signs. | — |
Countries
Japan
Contacts
Public ContactYuji Suzuki
Hamamatsu University School of Medicine Department of Anesthesiology and Intensive Care Medicine
Outcome results
None listed